BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15998957)

  • 1. Use of physician profiles to influence prescribing of topical corticosteroids.
    Sketris IS; Kephart G; Cooke CA; Skedgel CD; McLean-Veysey PR;
    Can J Clin Pharmacol; 2005; 12(2):e186-97. PubMed ID: 15998957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical corticosteroid prescribing patterns following changes in drug benefit status.
    Campbell CA; Cooke CA; Weerasinghe SD; Sketris IS; McLean-Veysey PR; Skedgel CD
    Ann Pharmacother; 2003 Jun; 37(6):787-93. PubMed ID: 12773062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.
    Barozzi N; Tett SE
    Clin Ther; 2009 Apr; 31(4):849-61. PubMed ID: 19446158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
    Balkrishnan R; Camacho FT; Pearce DJ; Kulkarni AS; Spencer L; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2005; 4(6):699-706. PubMed ID: 16302555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia.
    Cooke C; Nissen L; Sketris I; Tett SE
    Clin Ther; 2005 Apr; 27(4):497-508. PubMed ID: 15922822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries.
    Sketris IS; Kephart GC; Frail DM; Skedgel C; Allen MJ
    Pharmacotherapy; 2004 Jun; 24(6):784-91. PubMed ID: 15222669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland.
    Boyter AC; Steinke DT
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):203-9. PubMed ID: 15624197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of wet nebulized inhaled respiratory medications under criteria-based reimbursement guidelines in a publicly funded Seniors' Pharmacare Program in Nova Scotia, Canada.
    Bowles SK; Sketris I; Kephart G;
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):120-8. PubMed ID: 17719514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using aggregate data on dispensed drugs to evaluate the quality of prescribing in urban primary health care in Sweden.
    Wettermark B; Bergman U; Krakau I
    Public Health; 2006 May; 120(5):451-61. PubMed ID: 16513149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of prescribing for childhood eczema: evidence from a community-based study.
    Santer M; Lewis-Jones S; Fahey T
    Clin Exp Dermatol; 2006 Sep; 31(5):671-3. PubMed ID: 16901307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis.
    Marshall D; Gough J; Grootendorst P; Buitendyk M; Jaszewski B; Simonyi S; Jivraj F; Macleod S
    J Health Serv Res Policy; 2006 Jan; 11(1):13-20. PubMed ID: 16378528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
    Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing trends in asthma: a longitudinal observational study.
    Turner S; Thomas M; von Ziegenweidt J; Price D
    Arch Dis Child; 2009 Jan; 94(1):16-22. PubMed ID: 18701558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical corticosteroids in infants: prescribing pattern and prescribing errors in Bahrain.
    Al Khaja KA; Damanhori AH; Al-Ansari TM; Sequeira RP
    Pharm World Sci; 2007 Aug; 29(4):395-9. PubMed ID: 17295089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit of prescribing practices of topical corticosteroids in outpatient dermatology clinics in north Palestine.
    Sweileh WM
    East Mediterr Health J; 2006; 12(1-2):161-9. PubMed ID: 17037234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term impact of the women's health initiative on HRT.
    Parente L; Uyehara C; Larsen W; Whitcomb B; Farley J
    Arch Gynecol Obstet; 2008 Mar; 277(3):219-24. PubMed ID: 17713777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of antenatal corticosteroid prescribing 1998-2004.
    Polyakov A; Cohen S; Baum M; Trickey D; Jolley D; Wallace EM
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):42-5. PubMed ID: 17261099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing use of more potent treatments for psoriasis.
    Strowd LC; Yentzer BA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2009 Mar; 60(3):478-81. PubMed ID: 19058875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.